DrugPatentWatch Database Preview
Profile for United States of America Patent: 6395767
US Patent Family Members and Approved Drugs for United States of America Patent: 6395767
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | Jul 31, 2023 | Astrazeneca Ab | KOMBIGLYZE XR | metformin hydrochloride; saxagliptin hydrochloride |
➤ Sign Up | Jul 31, 2023 | Astrazeneca Ab | ONGLYZA | saxagliptin hydrochloride |
➤ Sign Up | Jul 31, 2023 | Astrazeneca Ab | QTERN | dapagliflozin; saxagliptin hydrochloride |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |